Surgical treatment of varicose veins and @entity1211 in XXXX .

@entity1 @entity3030 @entity1184 @entity600 @entity1150 @entity1151 @entity751 @entity158 @entity4917 @entity361 @entity1211
BACKGROUND: @entity4917 ( @entity4917 ) is a mixed @entity361 characterised by varicose veins, @entity1211 , and @entity1184 of soft tissue and bone. The purpose of this study was to evaluate the surgical outcomes in @entity4917 @entity1 to provide standards for comparison with endovenous therapy. METHODS: The clinical data of consecutive @entity1 with @entity4917 who underwent open venous surgical treatment between January 1987 and December 2008 were reviewed. Demographics, clinical presentation, operative data, and clinical outcomes were recorded. Follow-up information was obtained from the medical records, mailed questionnaires and phone calls. Descriptive statistics, the Kaplan-Meier method and Log-rank statistics were used where appropriate. RESULTS: Twenty-seven females and 22 males, (mean age 26.5 years, range 7.7-55.8) were included in this study. All had varicose veins, 36 (73%) had limb @entity1184 , and 33 (67%) had @entity600 , with two of three clinical features present in all. The most frequent symptom was @entity158 (N   =   43, 88%). Forty-nine @entity1 underwent operations on 53 limbs. Stripping of the GSV, small and accessory saphenous and lateral embryonic veins was performed in 17 (32%), 10 (19%), 9 (17%), and 15 (28%) limbs, respectively. Two @entity1 developed @entity1150 , one had @entity1151 ( @entity1151 ), and one @entity1 had @entity3030 . Freedom from disabling @entity158 at 1, 3 and 5 years was 95%, 77% and 59%, respectively, and freedom from secondary procedures was 78% at 3 years, and 74% at 5 years. At the last follow-up visit, the venous clinical severity score had decreased from 9.48        3.27 to 6.07        3.20 (P   <   0.001). CONCLUSIONS: In selected symptomatic @entity1 with @entity751 , open surgical treatment is safe and durable. Three-fourths of the @entity1 remain free of disabling @entity158 at five years, but secondary procedures are required in one-fourth of the @entity1 . These data can serve as standards for comparison of endovenous therapy for @entity751 .
